Odyssey Health (ODYY) Net Income (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Odyssey Health | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -49.14% |
| Oct 31, 2025 | -85.72% |
| Jul 31, 2025 | -12.67% |
| Apr 30, 2025 | 13.44% |
| Jan 31, 2025 | 66.06% |
| Oct 31, 2024 | -521.89% |
| Jul 31, 2024 | 132.37% |
| Apr 30, 2024 | 63.47% |
| Jan 31, 2024 | -141.41% |
| Oct 31, 2023 | 33.92% |
| Jul 31, 2023 | 36.58% |
| Apr 30, 2023 | 23.60% |
| Jan 31, 2023 | 21.80% |
| Oct 31, 2022 | -6.78% |
| Jul 31, 2022 | 35.06% |
| Apr 30, 2022 | -41.86% |
| Jan 31, 2022 | -32.71% |
| Oct 31, 2021 | 43.24% |
| Jul 31, 2021 | 76.71% |
| Apr 30, 2021 | -1,332.38% |
| Jan 31, 2021 | -22.18% |
| Oct 31, 2020 | 46.58% |
| Jul 31, 2020 | -33.30% |
| Apr 30, 2020 | -66.28% |
| Jan 31, 2020 | 57.58% |
| Oct 31, 2019 | 93.95% |
| Jul 31, 2019 | -37,195.89% |
| Apr 30, 2019 | 41.05% |
| Jan 31, 2019 | -53.21% |
| Oct 31, 2018 | 29.73% |
| Jul 31, 2018 | -34.43% |
| Apr 30, 2018 | 70.24% |
| Jan 31, 2018 | -289.92% |
| Oct 31, 2017 | 2.13% |
| Jul 31, 2017 | 19.03% |
| Apr 30, 2017 | -156.67% |
| Jan 31, 2017 | -42.54% |
| Oct 31, 2016 | 40.63% |
| Jul 31, 2016 | -350.09% |
| Apr 30, 2016 | 49.18% |
| Jan 31, 2016 | 35.57% |
| Oct 31, 2015 | -3.89% |
| Jul 31, 2015 | 43.39% |
| Apr 30, 2015 | 16.12% |
| Jan 31, 2015 | -16.53% |